<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34186367</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0334</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Diabetes &amp; metabolic syndrome</Title><ISOAbbreviation>Diabetes Metab Syndr</ISOAbbreviation></Journal><ArticleTitle>Proposed integrative model for post-COVID symptoms.</ArticleTitle><Pagination><StartPage>102159</StartPage><MedlinePgn>102159</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dsx.2021.05.032</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1871-4021(21)00176-4</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">To propose an integrative model for post-COVID symptoms by considering the absence/presence of previous symptomatology.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched different databases for original articles and reviews on post-COVID symptoms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The first consideration is to define which symptoms are of "new-onset" (symptoms never experienced by a patient before COVID-19 and experienced the first time after) and which symptoms are "exacerbated" (symptoms experienced by a patient prior to COVID-19 but aggravated later) after infection. The second consideration includes defining "persistent" (symptoms experienced at the acute phase and continuing after without remission period) and "delayed-onset" (symptoms not experienced at the acute phase of the infection but appearing after a "latency period"). This model integrates predisposing individual factors, biological factors associated to the severity of disease, hospitalization/treatment factors, and outbreak surrounding factors which may promote post-COVID.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Since current literature on post-COVID is heterogeneous, this integrative model could help to a better characterization of long-COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), Madrid, Spain. Electronic address: cesar.fernandez@urjc.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Florencio</LastName><ForeName>Lidiane L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Mayordomo</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuadrado</LastName><ForeName>Mar&#xed;a L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, Madrid, Spain; Department of Medicine, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palacios-Ce&#xf1;a</LastName><ForeName>Domingo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raveendran</LastName><ForeName>Arkiath Veettil</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Govt Medical College, Kozhikode, Kottayam, Manjeri, Kerala, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Diabetes Metab Syndr</MedlineTA><NlmUniqueID>101462250</NlmUniqueID><ISSNLinking>1871-4021</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Classification</Keyword><Keyword MajorTopicYN="N">Definition</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Persistent</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword></KeywordList><CoiStatement>Declaration of competing interest No conflict of interest is declared by the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>20</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34186367</ArticleId><ArticleId IdType="pmc">PMC8168334</ArticleId><ArticleId IdType="doi">10.1016/j.dsx.2021.05.032</ArticleId><ArticleId IdType="pii">S1871-4021(21)00176-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marshall M. The lasting misery of coronavirus long-haulers. Nature. 2020;585:339&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">32929257</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268:113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Emergency use ICD codes for COVID-19 disease outbreak. Available at: https://www.who.int/standards/classifications/classification-of-diseases/emergency-use-icd-codes-for-covid-19-disease-outbreak.</Citation></Reference><Reference><Citation>Nabavi N. Long COVID: how to define it and how to manage it. BMJ. 2020;370:m3489.</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. J&#xa0;Med Virol. 2020 doi: 10.1002/jmv.26624. Oct 23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V. Long COVID-19: challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr. 2020;15:145&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevanc R., Sashidharand S. Long COVID: an overview. Diabetes Metab Syndr. 2021 doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Florencio L.L. Defining post-COVID symptoms (Post-acute COVID, long COVID, persistent Post-COVID): an integrative classification. Int J Environ Res Publ Health. 2021;18:2621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A&#xa0;Proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324:2251&#x2013;2252.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., et al. Post-acute COVID-19 syndrome. Nat Med. 2021 doi: 10.1038/s41591-021-01283-z. Mar 22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021 Jan 1;2021.01.27.21250617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson G. Long Covid Forum Group. Research priorities for Long COVID: refined through an international multi-stakeholder forum. BMC Med. 2021;19:84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009733</ArticleId><ArticleId IdType="pubmed">33785027</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., Ballv&#xe9; A., Llaurad&#xf3; A., et al. Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40:1410&#x2013;1421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>Uygun &#xd6;., Erta&#x15f; M., Ekizo&#x11f;lu E., Bolay H., &#xd6;zge A., Kocasoy Orhan E., &#xc7;a&#x11f;atay A.A., Baykan B. Headache characteristics in COVID-19 pandemic-a survey study. J&#xa0;Headache Pain. 2020;21:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7552597</ArticleId><ArticleId IdType="pubmed">33050880</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Pinto M.D., Borelli J.L., Mehrabadi M.A., Abrihim H., Dutt N., et al. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: looking for clarity in the haze of the pandemic. medRxiv. 2021 Mar 5:2021.03.03.21252086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Fuensalida-Novo S., Palacios-Ce&#xf1;a M., G&#xf3;mez-Mayordomo V., Florencio L.L., et al. Myalgia as a symptom at hospital admission by Sars-Cov-2 infection is associated to persistent musculoskeletal pain as long-term post-covid sequelae: a case-control study. Pain. 2021 Apr 8 doi: 10.1097/j.pain.0000000000002306. (in press)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002306</ArticleId><ArticleId IdType="pubmed">33863864</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Mahase E. COVID could be four different syndromes, review suggests. BMJ. 2020;371:m3981.</Citation><ArticleIdList><ArticleId IdType="pubmed">33055076</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>